An organized set of primary and secondary sources covering clinical background, drug-safety signals, and patient-safety considerations.
Treatment for severe PPHN after Zoloft: A Detailed Overview โ detailed background and analysis.
Reference: U.S. Food and Drug Administration (FDA)
Authoritative source for clinical, regulatory, and public-health background reading.
Reference: Centers for Disease Control and Prevention (CDC)
Authoritative source for clinical, regulatory, and public-health background reading.
Reference: Mayo Clinic โ Diseases & Conditions
Authoritative source for clinical, regulatory, and public-health background reading.